Columbia Care Statement About Virginia’s Updated Law for its Medical Cannabis Program

June 30, 2022NEW YORKColumbia Care Inc.(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in theU.S., released the following statement in response to Virginia’s new law regarding patient registration for its medical cannabis program. Effective July 1, once patients receive a written certification from a registered practitioner, they can visit any licensed dispensary. They will no longer need to show proof of registration with the Virginia Board of Pharmacy (BOP).

“We applaud this step in making medical cannabis more accessible and affordable for patients,” said Nicholas Vita, CEO, Columbia Care. “Not only will this programmatic change help in clearing the backlog of thousands of patients who have been waiting for access to this life-changing medicine, but it will also facilitate the addition of new patients to the program. With this streamlined process and elimination of registration fees, we anticipate the current base of more than 51,000 registered patients to grow at a meaningful, impactful pace. We are grateful to the lawmakers and the Board of Pharmacy who are normalizing medical cannabis for those Virginians who need it most.”

Columbia Care is licensed for 12 total retail locations in Virginia, four of which are active with the remaining eight in development. The Company operates nearly 148,000 square feet of existing cultivation and production, with the capacity to expand.

For more information about Columbia Care’s Virginia dispensaries, visit or

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives in Virginia. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10 dated May 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents filed by the Company with Canadian and U.S. securities regulatory authorities.

Investor Contact
Lee Ann Evans
SVP, Capital Markets

Media Contact
Lindsay Wilson
VP, Communications

Source:Columbia Care Inc.

<< Back to Press Releases